Insider · CIK 0002065965
Tim Watkins
Files at CTNM (Contineum Therapeutics, Inc.). First filing Dec 30, 2025, latest Mar 2, 2026.
Tim Watkins files SEC Form 4 as officer at CTNM (Contineum Therapeutics, Inc.). Since Dec 30, 2025, Tim Watkins has reported 0 open-market buys worth $0 and 3 open-market sells worth $149k, the latest filed on Mar 2, 2026.
A track record needs three past buys with six months of prices behind them; Tim Watkins has 0, so none is measured yet.
The newest scored trade: sold $54k of CTNM on Mar 2, 2026, filed Mar 2, 2026, scored 22 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $149k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CTNM: Contineum Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Contineum Therapeutics, Inc. | $54k 3,611 shares | -100% | +351% from low-4% from high | |
| 22Weak | Contineum Therapeutics, Inc. | $51k 3,611 shares | -100% | +324% from low0% from high | |
| 14Weak | Contineum Therapeutics, Inc. | $44k 3,611 shares | -100% | +255% from low-18% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 29, 2025 | CTNM Contineum Therapeutics, Inc. | 10,833 0.05% of outstanding | $134k | Dec 29, 2025 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | CTNM Contineum Therapeutics, Inc. | MOption exercise Class A Common Stock10b5-1 | +3,611 | $4.50 | $16k | 3,611 | Mar 2, 2026 |
| Mar 2, 2026 | CTNM Contineum Therapeutics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -3,611 | $15.02 | $54k | 0 | Mar 2, 2026 |
| Mar 2, 2026 | CTNM Contineum Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,611 | $0.00 | $0 | 249,167 | Mar 2, 2026 |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc. | MOption exercise Class A Common Stock10b5-1 | +3,611 | $4.50 | $16k | 3,611 | Jan 30, 2026 |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -2,800 | $14.09 | $39k | 811 | Jan 30, 2026 |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -811 | $14.48 | $12k | 0 | Jan 30, 2026 |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,611 | $0.00 | $0 | 252,778 | Jan 30, 2026 |
| Jan 30, 2026 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +160,000 | $0.00 | $0 | 160,000 | Jan 30, 2026 |
| Dec 29, 2025 | CTNM Contineum Therapeutics, Inc. | MOption exercise Class A Common Stock10b5-1 | +3,611 | $4.50 | $16k | 3,611 | Dec 30, 2025 |
| Dec 29, 2025 | CTNM Contineum Therapeutics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -3,611 | $12.06 | $44k | 0 | Dec 30, 2025 |
| Dec 29, 2025 | CTNM Contineum Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,611 | $0.00 | $0 | 256,389 | Dec 30, 2025 |
| Apr 28, 2025 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +260,000 | $0.00 | $0 | 260,000 | Apr 28, 2025 |
| Apr 28, 2025 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Apr 28, 2025 |
Questions about Tim Watkins
Answered from the filings on this page, as of the latest one.
Is Tim Watkins buying or selling?
In the last 12 months Tim Watkins reported 0 open-market buys worth $0 and 3 open-market sells worth $149k on SEC Form 4; the latest was sold $54k of CTNM on Mar 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Tim Watkins's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tim Watkins has 0.
Where does Tim Watkins file Form 4?
Tim Watkins has filed Form 4 at CTNM (Contineum Therapeutics, Inc.) as CMO & Head of Development. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.